Viemed Healthcare, Inc. provided earnings guidance for the first quarter of 2024. For the quarter, the company expects to generate net revenues of approximately $49.7 million to $51.0 million during the first quarter of 2024 and assumes that the 75/25 blended Medicare reimbursement rate adjustment in non-rural, non-competitive bid areas is not extended.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.35 USD | +1.95% | +3.21% | +6.37% |
Apr. 02 | Viemed Healthcare, Inc. acquired an unknown majority interest in East Alabama Homemed, LLC. | CI |
Mar. 18 | Viemed Healthcare, Inc.(NasdaqCM:VMD) added to S&P TMI Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.37% | 324M | |
-28.69% | 70.69B | |
+14.32% | 81.84B | |
+9.37% | 29.03B | |
-11.43% | 16.97B | |
+0.32% | 16.83B | |
-0.24% | 15.28B | |
+5.85% | 12.41B | |
+33.40% | 12.26B | |
-31.40% | 11.83B |
- Stock Market
- Equities
- VMD Stock
- News Viemed Healthcare, Inc.
- Viemed Healthcare, Inc. Provides Earnings Guidance for the First Quarter of 2024